ATTO

Attovia Therapeutics Inc

• Seeking Alpha·09/05 06:30

  Primary Markets Group August IPO Update

• NASDAQ·09/04 18:36

  5 Biotech And Medical Device Stocks In Focus: Pro-Dex, Modular Medical, ENvue Medical & More

• Benzinga·09/04 15:26

  Quanex Building Products, Concrete Pumping, SanDisk And Other Big Stocks Moving Higher On Friday

• TipRanks·09/04 10:30

  Analysts Offer Insights on NA Companies: Attovia Therapeutics, Inc. (ATTO) and Navan, Inc. Class A (NAVN)

• NASDAQ·09/04 09:15

  Biotech Stocks At 52-Week Highs - ATTO, HALO, IKT, TVTX, ATRC

• NASDAQ·09/03 16:47

  Attovia's Q2 Loss Expands With Increased Trials For ATTO-1310; Plans Phase 2 For Q1 '27

• TipRanks·09/03 15:55

  Sam Slutsky Reiterates Buy on Attovia, Maintains $45 Price Target on Strong Early ATTO-1310 Data and Robust Cash Runway

• TipRanks·09/03 13:05

  Morgan Stanley Gives a Buy Rating to Attovia Therapeutics, Inc. (ATTO)

• TipRanks·09/03 11:50

  Analysts Offer Insights on NA Companies: Fastenal Company (FAST) and Attovia Therapeutics, Inc. (ATTO)

• TipRanks·09/02 20:15

  Attovia reports Q2 EPS ($4.88), consensus ($4.61)

• Benzinga·09/02 20:09

  Attovia Therapeutics Q2 EPS $(4.88) Misses $(4.62) Estimate, Sales $450.000K

• Dow Jones·09/02 20:07

  *Attovia Therapeutics: Upsized IPO Proceeds of $332.4 M Helps Extend Cash Runway Into 2030 >ATTO

• Dow Jones·09/02 20:07

  *Attovia Therapeutics 2Q Rev $450,000 >ATTO

• Dow Jones·09/02 20:05

  Press Release: Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

• Dow Jones·09/02 20:05

  *Attovia Therapeutics 2Q Loss $20.7M >ATTO